Kamada Ltd. (KMDA)

NMS – Real vaqt narxi. Valyuta: USD

7.71

-0.72 (-8.54%)

Bozor ochiq: May 13, 2026, 10:21 AM EDT

08.05.2026

Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics

Get a deeper insight into the potential performance of Kamada (KMDA) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

06.05.2026

Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026

REHOVOT, Israel and HOBOKEN, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.

26.03.2026

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

REHOVOT, Israel and HOBOKEN, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that the U.S. Food and Drug Administration (FDA) has approved Kamada Plasma's collection center in San Antonio, TX. The approval was obtained following an on-site inspection made by the FDA during February 2026.

11.03.2026

Kamada Ltd. (KMDA) Q4 2025 Earnings Call Transcript

11.03.2026

Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Kamada (KMDA) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

11.03.2026

Kamada (KMDA) Q4 Earnings and Revenues Miss Estimates

Kamada (KMDA) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.07 per share a year ago.

11.03.2026

Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth

REHOVOT, Israel, and HOBOKEN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced financial results for the three months and full-year ended December 31, 2025.

Videolar

No Data

There is no data to display

Press-relizlar

26.03.2026

Kamada Ltd. (KMDA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Kamada Ltd. (KMDA)

Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics

Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

Kamada Ltd. (KMDA) Q4 2025 Earnings Call Transcript

Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Kamada (KMDA) Q4 Earnings and Revenues Miss Estimates

Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth

Videolar

No Data

Press-relizlar

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics

Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

Kamada Ltd. (KMDA) Q4 2025 Earnings Call Transcript

Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Kamada (KMDA) Q4 Earnings and Revenues Miss Estimates

Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth

Videolar

No Data

Press-relizlar

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth

Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy

Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender

Search stocks

Kamada Ltd. (KMDA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Kamada Ltd. (KMDA)

Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics

Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

Kamada Ltd. (KMDA) Q4 2025 Earnings Call Transcript

Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Kamada (KMDA) Q4 Earnings and Revenues Miss Estimates

Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth

Videolar

No Data

Press-relizlar

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics

Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

Kamada Ltd. (KMDA) Q4 2025 Earnings Call Transcript

Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Kamada (KMDA) Q4 Earnings and Revenues Miss Estimates

Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth

Videolar

No Data

Press-relizlar

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth

Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy

Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender